D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosis

Journal of Rheumatology

Volumn 32, Issue SUPPL. 76, 2005, Pages 1-3

  Sambrook, Philip N ^a   Schacht, Erich ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; CALCITRIOL; CALCITRIOL DERIVATIVE; GLUCOCORTICOID; OXYGENASE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR; 1-HYDROXYCHOLECALCIFEROL; BONE DENSITY CONSERVATION AGENT; HYDROXYCOLECALCIFEROL; VITAMIN;

ASTHMA; CONFERENCE PAPER; CORTICOSTEROID INDUCED OSTEOPOROSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FRACTURE; HUMAN; LONG TERM CARE; NONHUMAN; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VITAMIN D METABOLISM; ANIMAL; ARTICLE; OSTEOPOROSIS; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; GLUCOCORTICOIDS; HUMANS; HYDROXYCHOLECALCIFEROLS; OSTEOPOROSIS; VITAMINS;

EID: 24944483063     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Van Staa TP, Leufkens HGM, Abenhaim A, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
2. Schacht E. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 1999;65:317-27.
3. Godschalk M, Levy RJ, Downs RW. Glucocorticoids decrease vitamin D receptor numbers and gene expression in human osteosarcoma cells. J Bone Miner Res 1992;7:21-7.
4. Ebert R, Jovanovic M, Ulmer M, et al. Downregulation by nuclear factor kappa B of human 25-hydroxyvitamin D3 1 alpha-hydroxylase promoter. Mol Endocrinol 2004;18:2440-50.
5. Oelzner P, Müller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998;62:193-8.
6. Lempert UG, Minne HW Albrecht B, Scharla SH, Matthes F, Ziegler R. 1,25-dihydroxy-vitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO). Bone Miner 1989;7:149-58.
7. DeLuca HF, Cantorna MT. Vitamin D. Its role and uses in immunology. FASEB J 2001;15:2579-85.
8. Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003;144:5138-44.
9. Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004;52:230-6.
10. Ringe JD, Schacht E. Prevention and therapy of osteoporosis: The respective roles of plain vitamin D and alfacalcidol. Rheumatol Int 2004;24:189-97.
11. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. New Engl J Med 1993;328:1747-52.
12. Reginster JY, Kuntz D, Verdickt W, et al. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 1999;9:75-81.
13. Richy F, Ethgen O, Bruyere O, Reginster J-Y. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 2004;15:301-10.
14. de Nijs RNJ, Jacobs JWG, Algra A, Lems WF, Bijlsma JWJ. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int 2004;15:589-602.
15. Scharla SH, Schacht E, Bawey S, Kamilli I, Holle D, Lempert UG. Pleiotropic effects of alfacalcidol in elderly patients with rheumatoid arthritis, arthritis+rheuma 2003;23:268-74.
16. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001;44:1496-503.
17. Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int 2004;24:63-70.
18. Shane E, Addesso V, Namerow P, et al. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 2004;350:767-76.
19. Briffa NK, Keogh AM, Sambrook PN, Eisman JA. Reduction of immunosuppressive therapy requirement in heart transplantation by calcitriol. Transplantation 2003;75:2133-34.